By shrinking visceral fat stores, GLP-1s help decrease the release of inflammatory cytokines, which contributes to improved blood sugar control, lower blood pressure, and a healthier lipid profile
The decision to use tirzepatide and beta blockers together should be individualized based on the patient's complete medical profile, including their cardiovascular status, glycemic control, renal function, and overall treatment goals
Iwaya C, Nomiyama T, Komatsu S, Kawanami T, Tsutsumi Y, Hamaguchi Y, et al
Randomized trials and registry studies across multiple countries converge on the same finding including a Swedish study that found GLP-1 drugs associated with fewer alcohol-related hospitalizations than medications specifically approved for alcohol use disorder
Caruso, A